BiotechTube
PHARMASEAL

PHARMASEAL

London, United Kingdom· Est.
pharmaseal.co
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PHARMASEAL is a private, early-revenue stage company offering a unified, cloud-native software platform for clinical trial management. Its core product, Engility®, combines CTMS and eTMF functionalities to enhance collaboration, oversight, and operational efficiency for biopharma, medical device, CRO, and other life science clients. The company differentiates itself with rapid implementation, a flexible security model for sponsor-supplier collaboration, and a pricing model that is not user-based. Its strategy targets the growing need for cost-effective, agile, and integrated trial management solutions as clinical development becomes more complex.

Drug DeliveryMedical Devices

Technology Platform

Engility®: A unified, cloud-native Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) platform designed for collaboration, rapid implementation, and integrated trial management.

Opportunities

The growing complexity and cost of clinical trials drive demand for integrated, collaborative management platforms.
PHARMASEAL's cloud-native, unified CTMS/eTMF solution and volume-based pricing are well-suited to serve small-to-midsize biopharma, medical device companies, and CROs seeking agile, cost-effective alternatives to large legacy systems.
Expansion into adjacent verticals like animal health and nutraceuticals presents additional growth avenues.

Risk Factors

PHARMASEAL faces intense competition from established giants like Veeva and Medidata.
As a young, private company, it carries execution risks in scaling its sales, marketing, and customer success operations.
The platform must continuously meet stringent regulatory validation requirements; any failure could damage client trust and result in significant liability.

Competitive Landscape

The clinical trial software market is highly competitive, dominated by large players like Veeva Systems (Vault CTMS) and Medidata Solutions. PHARMASEAL competes by offering a unified platform with a strong focus on sponsor-CRO collaboration, rapid implementation timelines, and a non user-based pricing model. It targets clients who may find the larger enterprise solutions too costly, complex, or slow to deploy.

More companies in United Kingdom →